Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista colombiana de Gastroenterología
versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440
Resumen
JULIAO BANOS, Fabián. Medical therapy for inflammatory bowel disease. Rev Col Gastroenterol [online]. 2007, vol.22, n.4, pp.313-330. ISSN 0120-9957.
The optimal medical treatment of patients with inflammatory bowel disease requires that the treating physician obtain a good history, evaluate the patient, perform necessary diagnostic procedures, and then prescribe an appropriate treatment based in the evidence from controlled clinical trials. The goals of pharmacology treatment in patients with inflammatory bowel disease are to improve quality of life, reduce the risk of complications and avoid surgical interventions. The recommendations of the new Montreal classification with respect to Crohn`s Disease and Ulcerative Colitis might be used in our clinical practice. Finally, the introduction of biological therapy (Infliximab, adalimumab), has greatly improved the treatment options in the management of inflammatory bowel disease.
Palabras clave : Inflammatory Bowel Disease; Crohn`s Disease; Ulcerative Colitis; Montreal classification; biological therapy.